The National Museum of American History has curated a display to show artifacts related to Genentech’s history and role in the creation of the biotechnology industry. The exhibition, “The Birth of Biotech,” commemorates breakthrough scientific discoveries and the use of genetic engineering to make medicines that improve patients’ lives.
Scientific progress consistently changes the world in significant and sustaining ways. It can challenge long held assumptions, offer a foundation for new discoveries, and make the world a better place.
Making the world a better place is exactly what Herb Boyer and Bob Swanson hoped to achieve when they pioneered the use of recombinant DNA (rDNA) technology and founded Genentech.
The idea that the gene product of one organism can be produced and isolated completely revolutionized medicine. It gave birth to a whole new industry – biotechnology – and opened the door to create medicines never before believed possible.
Moreover, rDNA technology gave scientists across the world a tool to study life and disease at the molecular level, sparking further discovery and innovation.
Over the past 35 years, biotech has seen a number of innovations, but it’s still only the beginning. The future holds discoveries we have yet to imagine, and the shape of our industry has yet to be defined. We like to think of it as “The DNA Effect.”
The DNA Effect Panel
We are excited to celebrate the opening of the display at the National Museum of American History by hosting a panel discussion featuring Drs. Arthur Levinson, Kimberly Blackwell, George Church and Daniel Kraft.
Moderated by Matthew Herper, a senior editor at Forbes, the panel will discuss the impact of biotechnology on medicine and science, and what we can expect from the industry in the years to come. Read more about our distinguished panelists
Tune in to the live-streaming event at gene.com/biotech on October 24, 2013 at 7 p.m. EST
The onsite event is by invitation only. If you did not receive a formal invitation, please tune-in to the live-streaming broadcast of the panel discussion. For assistance, call 202-585-2055.